Herbert Loong: Daniel Goldstein shares insights and experiences in pharmacoeconomics
Herbert Loong shared on X:
“Thanks Daniel Goldstein for coming all the way from Israel to Hong Kong to share insights and experiences in pharmacoeconomics. Organised by Prof Vivian Lee and colleagues of CUHK pharmacy
Very engaged workshop together with stakeholders from academia, industry, patients representatives and the Hospital Authority.”
Source: Herbert Loong/X
Dr. Herbert H. F. Loong holds several prominent positions in oncology. He is the Chair-Elect of the International Affairs Committee, a Scientific Track Member (2022-2024), and the Track Leader for Sarcoma (2023) at the American Society of Clinical Oncology (ASCO).
Additionally, he has been promoted to Steering Committee Member at the Lung Cancer Policy Network. Dr. Loong is also the Chairperson of the Asia Pacific Coalition against Lung Cancer, a Board Member of the Connective Tissue Oncology Society, and a Committee Member of the International Association for the Study of Lung Cancer. He is an Associate Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong (CUHK).
